Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

3.65
Delayed Data
As of Apr 20
 +0.02 / +0.55%
Today’s Change
2.58
Today|||52-Week Range
5.66
+26.74%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization295.0K270.0K277.0K284.0K
 
 
 
 
 
 
Operating ExpensesGross Income-295.0K-270.0K-277.0K-284.0K
 
 
 
 
 
General Expenses20.5M23.4M20.3M24.1M
 
 
 
 
 
Research And Development15.2M18.3M15.7M15.7M
 
 
 
 
 
Total Operating Expenses20.8M23.7M20.6M24.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-20.8M-23.7M-20.6M-24.4M
 
 
 
 
 
Interest Expense On Debt17.0K12.0K8.0K13.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-19.8M-22.6M-19.4M-23.2M
 
 
 
 
 
Income Taxes-340.0K-75.0K-100.0K0.00
 
 
 
 
Net Income-20.2M-22.5M-19.3M-23.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS136.7M136.7M137.4M137.9M
 
 
 
 
 
Shares To Calculate EPS Diluted136.7M136.7M137.4M137.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.15-$0.16-$0.14-$0.17
 
 
 
 
 
EPS Diluted-$0.15-$0.16-$0.14-$0.17